The impact of multi-target stool DNA testing in clinical practice in the United States: A real-world evidence retrospective study
Widely endorsed screening modalities for colorectal cancer (CRC) include structural visualization (e.g. colonoscopy) and stool-based tests including multitarget stool DNA (mt-sDNA), fecal immunochemical tests (FIT), or high-sensitivity guaiac-based fecal occult blood tests (gFOBT). However, CRC scre...
Main Authors: | Lesley-Ann Miller-Wilson, Paul Limburg, Leah Helmueller, Maria João Janeiro, Paul Hartlaub |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Preventive Medicine Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211335522003527 |
Similar Items
-
Patterns of colorectal cancer screening and adherence rates among an average-risk population enrolled in a national health insurance provider during 2009–2018 in the United States
by: Henrik Kowalkowski, et al.
Published: (2023-12-01) -
Real‐world application of a fast stool DNA test for colorectal cancer screening in primary screening positive population
by: Yunfeng Zhu, et al.
Published: (2023-04-01) -
A Comparison of Single and Combined Schemes of Asia-Pacific Colorectal Screening, Faecal Immunochemical and Stool Deoxyribonucleic Acid Testing for Community Colorectal Cancer Screening
by: Ze Y, et al.
Published: (2023-03-01) -
Use of a mixed‐methods approach to develop a guidebook with messaging to encourage colorectal cancer screening among Black individuals 45 and older
by: Adjoa Anyane‐Yeboa, et al.
Published: (2023-09-01) -
Multitarget Stool mRNA Test for Detecting Colorectal Cancer Lesions Including Advanced Adenomas
by: Elizabeth Herring, et al.
Published: (2021-03-01)